Intraoperative Lidocaine or Dexmedetomidine to Help Postoperative Pain After Urethral Reconstruction
Official title: Effects of Intravenous Lidocaine and Dexmedetomidine Infusions on Postoperative Pain and the Development of Chronic Pain Following Urethral Reconstruction Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial.
Run by Centre of Postgraduate Medical Education · NCT07676942 · Data updated 2026-11-12
This study tests whether giving lidocaine or dexmedetomidine during urethral reconstruction can reduce pain after surgery and lower the chance of long-lasting pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 80 (estimated) |
| Sponsor | Centre of Postgraduate Medical Education Academic / other |
| Locations | 1 site (Warsaw) |
| Status | Recruiting |
| Started | July 7, 2026 |
| Main results expected | June 2028 |
| Study ends | July 2028 |
| Registry record updated | October 9, 2026 |
| Trial ID | NCT07676942 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-75 scheduled for urethral reconstructive surgery, ASA I-III, able to consent, without known drug allergies to lidocaine or dexmedetomidine.
✕Probably not a fit
Patients with contraindications to lidocaine or dexmedetomidine, chronic pain conditions, or ongoing use of opioids, gabapentinoids, or antidepressants may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized approach compares perioperative intravenous lidocaine, dexmedetomidine, and placebo during urethral reconstructive surgery. It aims to measure postoperative pain intensity, recovery quality, and the development of chronic postoperative pain, including neuropathic features. The protocol uses established dosing within standard practice to assess potential benefits in pain modulation and opioid-sparing effects. Eligible participants are adults aged 18-75 with ASA I-III status undergoing urethral reconstruction. Outcomes will inform whether perioperative pharmacologic strategies can reduce the transition from acute to chronic pain in this surgical population.
Why it matters
Potential benefit: If successful, patients may experience lower acute pain, faster recovery, and a reduced risk of chronic postoperative pain after urethral reconstruction.
How similar studies have gone: Prior perioperative use of lidocaine and dexmedetomidine for analgesia has shown pain-reduction and opioid-sparing effects in various surgeries, though data specific to urethral reconstruction and CPP prevention remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA status less or equal 3 * Scheduled for reconstructive surgery of urethra * Able to understand information provided and to sign informed consent for participation in the study Exclusion Criteria: * known allergy to one of the investigated medications * current chronic pain * known chronic use of opioids, gabapentinoids and antidepressants
Where it's running
-
Department of Anesthesiology and Intensive Care, Centre of Postgraduate Medical Education
Warsaw, Poland Recruiting
Study contacts
- Study coordinator: Bartosz Horosz, MD,PhD
- Email: bartosz.horosz@gmail.com
- Phone: 0048225841122
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Urethral Resistive Index (URI) as a non-invasive test for urethral blockage
This project tests a new, painless urine-flow measure called the Urethral Resistive Index (URI) to see if it can detect urethral strictures in men.
-
Comparing cheek (buccal) tissue versus penile skin grafts for repairing long anterior urethral strictures
This will test whether cheek (buccal) tissue or penile skin works better to repair long anterior urethral strictures in men who need urethroplasty.
-
Paclitaxel-coated versus standard dilatation balloon for recurrent urethral stricture
This trial tests if a paclitaxel-coated dilatation balloon (Optilume) reduces the chance of urethral stricture coming back compared with a non-coated balloon in adults who have had previous dilations or DVIU.
-
Database for patients with urethral stricture undergoing surgery
This study is trying to gather information from patients with urethral stricture who are having surgery to see how well different surgical methods work and how they affect quality of life.
-
Study on urethroplasty for urethral stricture disease
This study is testing how well urethroplasty works for treating urethral stricture disease in different groups of people, including men, women, transgender individuals, and children.
-
Using engineered urethral constructs to treat urethral strictures in men
This study is testing a new way to treat urethral strictures in men by using specially grown tissue from their own bladder to see if it helps them feel better over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.